Dr Gary Bernard Mazzanti, MD | |
701 Jordan St, Suite A, Shreveport, LA 71101-4660 | |
(318) 221-6700 | |
(318) 221-6701 |
Full Name | Dr Gary Bernard Mazzanti |
---|---|
Gender | Male |
Speciality | Undersea And Hyperbaric Medicine |
Experience | 38 Years |
Location | 701 Jordan St, Shreveport, Louisiana |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1174629299 | NPI | - | NPPES |
1399256 | Medicaid | LA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207PE0005X | Emergency Medicine - Undersea And Hyperbaric Medicine | MD020779 (Louisiana) | Primary |
207Q00000X | Family Medicine | MD020779 (Louisiana) | Secondary |
Mailing Address | Practice Location Address |
---|---|
Dr Gary Bernard Mazzanti, MD 701 Jordan St, Suite A, Shreveport, LA 71101-4660 Ph: (318) 221-6700 | Dr Gary Bernard Mazzanti, MD 701 Jordan St, Suite A, Shreveport, LA 71101-4660 Ph: (318) 221-6700 |
News Archive
Exalenz Bioscience, a leader in developing and marketing non-invasive medical devices for diagnosing and monitoring a range of gastrointestinal and liver diseases, today announced the initiation of a clinical study designed to investigate its BreathID test to non-invasively detect primary liver cancer, also known as Hepatocellular Carcinoma (HCC).
Researchers have shown that a peptide (a chain of amino acids) called iRGD helps co-administered drugs penetrate deeply into tumor tissue. The peptide has been shown to substantially increase treatment efficacy against human breast, prostate and pancreatic cancers in mice, achieving the same therapeutic effect as a normal dose with one-third as much of the drug.
Meningitis is a relatively rare disease, with our estimates for the incidence of meningitis in the UK being about 3.2 cases of meningitis per 100,000 adults. Crucially, bacterial meningitis is linked to significant morbidity and mortality - up to 30% mortality in pneumococcal meningitis cases.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has filed a patent infringement lawsuit against Tekmira Pharmaceuticals Corporation in the U.S. District Court of the District of Massachusetts.
CryoLife, Inc., a leading medical device and tissue processing company focused on cardiac and vascular surgery, announced today its results for the fourth quarter and full year of 2014.
› Verified 4 days ago
David James Caltrider, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1501 Kings Highway, Emergency Medicine, Shreveport, LA 71130 Phone: 318-626-2326 | |
Dr. Craig Florea, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2600 Greenwood Rd, Shreveport, LA 71103 Phone: 318-212-4500 | |
Dr. Lacey Whited, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1501 Kings Hwy, Department Of Emergency Medicine, Shreveport, LA 71103 Phone: 318-675-6885 Fax: 318-675-6878 | |
Roy Brandhurst, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 8001 Youree Dr, Shreveport, LA 71115 Phone: 318-212-3500 Fax: 318-212-3505 | |
Joseph William Yarbrough Jr., DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1501 Kings Highway, Emergency Medicine, Shreveport, LA 71130 Phone: 318-626-1034 | |
Brett Horn, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1501 Kings Hwy, Department Of Emergency Medicine, Shreveport, LA 71103 Phone: 318-675-7261 Fax: 318-675-6878 | |
Brian T Dillon, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2600 Greenwood Rd, Shreveport, LA 71103 Phone: 318-212-4500 Fax: 318-212-4143 |